Trial Profile
A retrospective trial evaluating the efficacy and toxicity of bevacizumab combined with cisplatin in late-stage malignant carcinoma patients with malignant pleural effusion and ascites
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Mar 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Cisplatin (Primary) ; Bevacizumab; Cisplatin
- Indications Ascites; Cancer; Malignant pleural effusion
- Focus Adverse reactions; Therapeutic Use
- 28 Mar 2016 New trial record
- 01 Mar 2016 Results (n=43) published in the Anticancer Research.